智通财经APP获悉，艾迪康控股(09860)午后涨超16%，截至发稿，涨14.16%，报8.06港元，成交额2870.19万港元。
消息面上，中国疾控中心最新数据称，目前流感病毒阳性率持续上升，其中99%以上为甲流。据悉，艾迪康控股是中国三大独立医学检验实验室(ICL)之一。公司在全国范围内拥有33家自营实验室，组成的集成网络为医院和体检中心提供4000多种检验服务。
华创证券此前指出，国内ICL市场渗透率相较于国外仍有较大差距，在分级诊疗推进、医保控费压力加大、DRG/DIP付费方式改革、基层医疗建设的推动下，国内ICL行业有望进入快速发展期。此外疫情期间的应收账款持续稳定收回，24年计提应收减值有望收窄。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.